Cargando…

Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences

SIMPLE SUMMARY: Malignant glioma has a poor prognosis, especially in recurrent situations. Interstitial photodynamic therapy (iPDT) uses light delivered by implanted light-diffusing fibers to activate a photosensitizing agent to induce tumor cell death. This study examined iPDT for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lietke, Stefanie, Schmutzer, Michael, Schwartz, Christoph, Weller, Jonathan, Siller, Sebastian, Aumiller, Maximilian, Heckl, Christian, Forbrig, Robert, Niyazi, Maximilian, Egensperger, Rupert, Stepp, Herbert, Sroka, Ronald, Tonn, Jörg-Christian, Rühm, Adrian, Thon, Niklas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067827/ https://www.ncbi.nlm.nih.gov/pubmed/33917116 http://dx.doi.org/10.3390/cancers13081767

Ejemplares similares

Interstitial photodynamic therapy for newly diagnosed glioblastoma
por: Quach, Stefanie, et al.
Publicado: (2023)

Interrelation between Spectral Online Monitoring and Postoperative T1-Weighted MRI in Interstitial Photodynamic Therapy of Malignant Gliomas
por: Aumiller, Maximilian, et al.
Publicado: (2021)

Interstitial Photodynamic Therapy of Glioblastomas: A Long-Term Follow-up Analysis of Survival and Volumetric MRI Data
por: Foglar, Marco, et al.
Publicado: (2023)

PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression
por: Weller, Jonathan, et al.
Publicado: (2021)

Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas
por: Katzendobler, Sophie, et al.
Publicado: (2022)

The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine
por: Katzendobler, Sophie, et al.
Publicado: (2022)

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
por: Weller, Jonathan, et al.
Publicado: (2022)

Frequency and Prognostic Relevance of Volumetric MRI Changes in Contrast- and Non-Contrast-Enhancing Tumor Compartments between Surgery and Radiotherapy of IDHwt Glioblastoma
por: Teske, Nico, et al.
Publicado: (2023)

Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas
por: Hadi, Indrawati, et al.
Publicado: (2021)

Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas
por: Watson, Juliana, et al.
Publicado: (2020)

Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers
por: Karschnia, Philipp, et al.
Publicado: (2021)

Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status
por: Weller, Jonathan, et al.
Publicado: (2023)

Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)

Early treatment of complex located pediatric low‐grade gliomas using iodine‐125 brachytherapy alone or in combination with microsurgery
por: Kunz, Mathias, et al.
Publicado: (2015)

The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents
por: Siller, Sebastian, et al.
Publicado: (2021)

Nuclear translocation of beta catenin in patients with Rathke cleft cysts—clinical and imaging characteristics and risk of recurrence
por: Schmutzer, Michael, et al.
Publicado: (2023)

Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
por: Teske, Nico, et al.
Publicado: (2021)

Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
por: Quach, Stefanie, et al.
Publicado: (2022)

Multifocal high-grade glioma radiotherapy safety and efficacy
por: Fleischmann, Daniel Felix, et al.
Publicado: (2021)

O(6)-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation
por: Kreth, Simone, et al.
Publicado: (2011)

Postoperative [(68)Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1
por: Teske, Nico, et al.
Publicado: (2023)

Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
por: Karschnia, Philipp, et al.
Publicado: (2020)

Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial
por: Bodensohn, Raphael, et al.
Publicado: (2021)

Advanced imaging findings in stroke-like migraine attacks after radiation therapy (SMART) syndrome
por: Teske, Nico, et al.
Publicado: (2022)

The surgical perspective in precision treatment of diffuse gliomas
por: Thon, Niklas, et al.
Publicado: (2019)

Intramedullary pilomyxoid astrocytoma with intracerebral metastasis exhibiting oligoden-droglioma-like features
por: Eigenbrod, Sabina, et al.
Publicado: (2012)

Intraoperative ultrasonography in laminectomy for degenerative cervical spondylotic myelopathy: a clinical and radiological evaluation
por: Biczok, Annamaria, et al.
Publicado: (2022)

Detection of impending perfusion deficits by intraoperative computed tomography (iCT) in aneurysm surgery of the anterior circulation
por: Thorsteinsdottir, Jun, et al.
Publicado: (2021)

Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
por: Wachowska, Małgorzata, et al.
Publicado: (2011)

Multimodal therapy of cavernous sinus meningioma: Impact of surgery and (68)Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome
por: Hadi, Indrawati, et al.
Publicado: (2021)

Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I
por: Biczok, Annamaria, et al.
Publicado: (2021)

Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma
por: Dorostkar, Mario M, et al.
Publicado: (2022)

Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy
por: Casas, A, et al.
Publicado: (2001)

Photodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA)
por: Yonemura, Yutaka, et al.
Publicado: (2017)

Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
por: Lou, Liang, et al.
Publicado: (2023)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia
por: Fisher, Carl J., et al.
Publicado: (2017)

5-ALA Fluorescence in Native Pituitary Adenoma Cell Lines: Resection Control and Basis for Photodynamic Therapy (PDT)?
por: Nemes, Andrei, et al.
Publicado: (2016)

Use of diffusion-weighted MRI to modify radiosurgery planning in brain metastases may reduce local recurrence
por: Zakaria, Rasheed, et al.
Publicado: (2016)

Photodynamic therapy in glioblastoma: Detection of intraoperative inadvertent 5-ALA mediated photodynamic therapeutical effect after gross total resection
por: Ferrés, Abel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2e3ils9g9uip0ndca9p0h5002o